The newsroom includes access to CHA News, which provides timely information to members every Thursday and is at the core of CHA benefits. In addition, it is also home to resources such as toolkits and talking points designed to help member hospitals and health systems communicate with internal and external audiences on a range of current health care-related issues. Links to CHA media statements and press releases can also be found here.
Newsroom
CHA Issues Summary of DMEPOS Proposed Rule
CHA has issued a detailed summary, prepared by Health Policy Alternatives, of the proposed rule updating payment methodologies for the Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) fee schedule for calendar year 2021, as well as Healthcare Common Procedure Coding System (HCPCS) issues.
Updates for the Week of Nov. 9
The Centers for Medicare & Medicaid Services issued the following updates this week:
SNF 3-Day Rule Billing
Home Health Prospective Payment System Rate Update for Calendar Year 2021
Manual Updates Related to the Hospice Election Statement and the Implementation of the Election Statement Addendum
Updates to Skilled Nursing Facility Patient Driven Payment Model Claims
Nov. 19: IPFQR Program FY 2021 Data Review Webinar
HHS to Host Webinar on Hospital Data Reporting Requirements Tomorrow, Nov. 13
The Health & Human Services’ (HHS) Office of Intergovernmental and External Affairs will host an additional webinar on the updated guidance for its interim final rule on COVID-19 data reporting requirements tomorrow, Nov. 13, at 10 a.m. (PT). The webinar will include time for Q&A.
CHA Alert Urges Congress to Provide Additional Funding, Relief During Lame Duck Session
On Nov. 9, CHA issued an Advocacy Alert asking members to reach out to their representatives about helping protect providers with much-needed additional funding and relief during the lame duck congressional session.
CMS Announces Coverage, Payment Policies for COVID-19 Monoclonal Antibody Therapies
Following the approval by the U.S. Food and Drug Administration (FDA) of emergency use authorization for the investigational monoclonal antibody therapy, bamlanivimab, the Centers for Medicare & Medicaid Services (CMS) announced it will cover monoclonal antibody therapies, with no beneficiary cost-sharing for the duration of the COVID-19 public health emergency.
Webinar Reveals Maternal Suicide Risk Factors
The Hospital Quality Institute (HQI) will hold a webinar, Preventing Suicide in the Year Following Birth: Lessons from California, to explain the findings from a recent California study on pregnancy-associated suicides. The members-only webinar will be held from 11 a.m. to noon (PT) on Nov. 17.
Grant Opportunity Available for GME-Eligible Hospitals
The California Health Care Foundation, in partnership with policy research group Mathematica, has issued a request for proposal (RFP) on feasibility grants to advance graduate medical education (GME) in California hospitals.
CMS Finalizes 2018 Proposed Rule for Medicaid Managed Care and CHIP
Earlier today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that revises Medicaid Managed Care and Children’s Health Insurance Program regulations intended to reduce state administrative burden and increase program flexibility. CHA provided written comments on CMS’ proposed rule in January 2019.
Updated COVID-19 Infection Control Guidance Released by CDC
On Nov. 4, the Centers for Disease Control and Prevention issued updated infection control guidance for the COVID-19 pandemic. It provides additional options for screening employees and visitors for COVID-19 – including implementing a system for employees to take their temperature prior to arrival at the facility and report the absence of fever and other COVID-19 symptoms electronically.
Biden Announces COVID-19 Task Force
President-elect Joe Biden has announced a COVID-19 advisory board, underscoring that his administration’s priority will be controlling the COVID-19 pandemic. The task force, which includes three Californians, will advise the incoming Biden administration as it prepares to orchestrate a federal response to the COVID-19 pandemic.